Sen. Pat Roberts sold Novavax (NVAX)
Sen. Pat Roberts (R-KS) · $1K–$15K · traded Oct 13, 2020
- Transaction
- Sold (full)
- Amount
- $1K–$15K
- Owner
- Spouse
- Traded
- Oct 13, 2020
- Disclosed
- Nov 5, 2020
- Days to disclose
- 23
- Asset type
- Stock
- As filed
- Novavax, Inc.
- Industry
- Biotechnology · Healthcare
Other trades in this filing
- Nov 5, 2020$1K–$15K
$1K–$15K · Traded Oct 13, 2020 · disclosed Nov 5, 2020 · Spouse
Recent Congress trades in NVAX
- Aug 30, 2020$1K–$15K
Sen. Pat Roberts (R-KS)
$1K–$15K · Traded Aug 17, 2020 · disclosed Aug 30, 2020 · Spouse
Company context for NVAX
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
NVAX: third_quarter 2026 lobbying report
Guidance navigating vaccine policy.
Public: Oct 18, 2026, 4:09 PM EDTOriginal source ↗NVAX: third_quarter 2026 lobbying report
Issues related to federal vaccine programs and vaccine regulatory frameworks. FDA funding and advocacy H.R.4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Public: Oct 18, 2026, 3:32 PM EDTOriginal source ↗NVAX: third_quarter 2026 lobbying report
Issues related to federal vaccine programs and vaccine regulatory frameworks
Public: Oct 14, 2026, 12:37 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.